Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-011-1817-3.

Title:
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours | Breast Cancer Research and Treatment
Description:
Amplification of chromosomal region 11q13, containing the cell cycle regulatory gene CCND1, is frequently found in breast cancer and other malignancies. It is associated with the favourable oestrogen receptor (ER)-positive breast tumour phenotype, but also with poor prognosis and treatment failure. 11q13 spans almost 14 Mb and contains more than 200 genes and is affected by various patterns of copy number gains, suggesting complex mechanisms and selective pressure during tumour progression. In this study, we used 32 k tiling BAC array CGH to analyse 94 CCND1-amplified breast tumours from sporadic, hereditary, and familial breast cancers to fine map chromosome 11q13. A set containing 281 CCND1-non-amplified breast tumours was used for comparisons. We used gene expression data to further validate the functional effect of gene amplification. We identified six core regions covering 11q13.1-q14.1 that were amplified in different combinations. The major core contained CCND1, whereas two cores were found proximal of CCND1 and three distal. The majority of the CCND1-amplified tumours were ER-positive and classified as luminal B. Furthermore, we found that CCND1 amplification is associated with a more aggressive phenotype within histological grade 2 tumours and luminal A subtype tumours. Amplification was equally prevalent in familial and sporadic tumours, but strikingly rare in BRCA1- and BRCA2-mutated tumours. We conclude that 11q13 includes many potential target genes in addition to CCND1.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cancer, breast, article, pubmed, google, scholar, cas, amplification, gene, ccnd, tumours, cell, borg, staaf, research, cyclin, res, lund, genes, vallonchristersson, university, holm, cancers, expression, genomic, johan, brca, access, data, patterns, chromosome, sporadic, familial, jönsson, arason, hegardt, genome, ringner, bmc, foundation, privacy, cookies, content, ccndamplified, barkardottir, receptor, array, clinical, molecular, genomics,

Topics {✒️}

high-resolution genomic profiles breakage-fusion-bridge cycle model chromosomal breakage-fusion-bridge events gene-expression profiles month download article/chapter breakage-fusion-bridge ccnd1+ adalgeir arason & rosa high-resolution mapping identifies author information authors gene expression-based outcome array-cgh data adalgeir arason low-malignant lipomatous tumors author correspondence 1007/s10549-009-0479 ccnd1 gene amplification full article pdf sciblu genomics centre gene expression profiling translational cancer research privacy choices/manage cookies gene expression data breast cancer online familial breast tumours swedish research council amplified breast tumours breast cancer -associations primary breast cancer premenopausal breast cancer breast cancer pathophysiologies postmenopausal breast cancer national health services gene signature prognostic ems1 gene expression strategic research ccnd1-amplified tumours copy number gains copy number imbalances check access instant access johan vallon-christersson van der sman commonly amplified 11q13 human breast cancer sporadic breast cancer familial breast cancers hormone receptor–positive oestrogen receptor expression swedish cancer society affecting cell motility

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours
         description:Amplification of chromosomal region 11q13, containing the cell cycle regulatory gene CCND1, is frequently found in breast cancer and other malignancies. It is associated with the favourable oestrogen receptor (ER)-positive breast tumour phenotype, but also with poor prognosis and treatment failure. 11q13 spans almost 14 Mb and contains more than 200 genes and is affected by various patterns of copy number gains, suggesting complex mechanisms and selective pressure during tumour progression. In this study, we used 32 k tiling BAC array CGH to analyse 94 CCND1-amplified breast tumours from sporadic, hereditary, and familial breast cancers to fine map chromosome 11q13. A set containing 281 CCND1-non-amplified breast tumours was used for comparisons. We used gene expression data to further validate the functional effect of gene amplification. We identified six core regions covering 11q13.1-q14.1 that were amplified in different combinations. The major core contained CCND1, whereas two cores were found proximal of CCND1 and three distal. The majority of the CCND1-amplified tumours were ER-positive and classified as luminal B. Furthermore, we found that CCND1 amplification is associated with a more aggressive phenotype within histological grade 2 tumours and luminal A subtype tumours. Amplification was equally prevalent in familial and sporadic tumours, but strikingly rare in BRCA1- and BRCA2-mutated tumours. We conclude that 11q13 includes many potential target genes in addition to CCND1.
         datePublished:2011-10-16T00:00:00Z
         dateModified:2011-10-16T00:00:00Z
         pageStart:583
         pageEnd:594
         sameAs:https://doi.org/10.1007/s10549-011-1817-3
         keywords:
             CCND1
            11q13
            Array comparative genomic hybridisation
            Breast cancer
            Gene amplification
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1817-3/MediaObjects/10549_2011_1817_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1817-3/MediaObjects/10549_2011_1817_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1817-3/MediaObjects/10549_2011_1817_Fig3_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:133
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Karolina Holm
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University, BMC C13
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Johan Staaf
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University, BMC C13
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Göran Jönsson
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University, BMC C13
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Johan Vallon-Christersson
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University, BMC C13
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Haukur Gunnarsson
               affiliation:
                     name:Landspitali University Hospital
                     address:
                        name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Adalgeir Arason
               affiliation:
                     name:Landspitali University Hospital
                     address:
                        name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
                        type:PostalAddress
                     type:Organization
                     name:University of Iceland
                     address:
                        name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Linda Magnusson
               affiliation:
                     name:University and Regional Laboratories, Skåne University Hospital, Lund University
                     address:
                        name:Department of Clinical Genetics, University and Regional Laboratories, Skåne University Hospital, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rosa B. Barkardottir
               affiliation:
                     name:Landspitali University Hospital
                     address:
                        name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
                        type:PostalAddress
                     type:Organization
                     name:University of Iceland
                     address:
                        name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cecilia Hegardt
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Markus Ringnér
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University, BMC C13
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Åke Borg
               affiliation:
                     name:Lund University
                     address:
                        name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University, BMC C13
                     address:
                        name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                        type:PostalAddress
                     type:Organization
                     name:Lund University
                     address:
                        name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours
      description:Amplification of chromosomal region 11q13, containing the cell cycle regulatory gene CCND1, is frequently found in breast cancer and other malignancies. It is associated with the favourable oestrogen receptor (ER)-positive breast tumour phenotype, but also with poor prognosis and treatment failure. 11q13 spans almost 14 Mb and contains more than 200 genes and is affected by various patterns of copy number gains, suggesting complex mechanisms and selective pressure during tumour progression. In this study, we used 32 k tiling BAC array CGH to analyse 94 CCND1-amplified breast tumours from sporadic, hereditary, and familial breast cancers to fine map chromosome 11q13. A set containing 281 CCND1-non-amplified breast tumours was used for comparisons. We used gene expression data to further validate the functional effect of gene amplification. We identified six core regions covering 11q13.1-q14.1 that were amplified in different combinations. The major core contained CCND1, whereas two cores were found proximal of CCND1 and three distal. The majority of the CCND1-amplified tumours were ER-positive and classified as luminal B. Furthermore, we found that CCND1 amplification is associated with a more aggressive phenotype within histological grade 2 tumours and luminal A subtype tumours. Amplification was equally prevalent in familial and sporadic tumours, but strikingly rare in BRCA1- and BRCA2-mutated tumours. We conclude that 11q13 includes many potential target genes in addition to CCND1.
      datePublished:2011-10-16T00:00:00Z
      dateModified:2011-10-16T00:00:00Z
      pageStart:583
      pageEnd:594
      sameAs:https://doi.org/10.1007/s10549-011-1817-3
      keywords:
          CCND1
         11q13
         Array comparative genomic hybridisation
         Breast cancer
         Gene amplification
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1817-3/MediaObjects/10549_2011_1817_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1817-3/MediaObjects/10549_2011_1817_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1817-3/MediaObjects/10549_2011_1817_Fig3_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:133
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Karolina Holm
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University, BMC C13
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Johan Staaf
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University, BMC C13
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Göran Jönsson
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University, BMC C13
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Johan Vallon-Christersson
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University, BMC C13
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Haukur Gunnarsson
            affiliation:
                  name:Landspitali University Hospital
                  address:
                     name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Adalgeir Arason
            affiliation:
                  name:Landspitali University Hospital
                  address:
                     name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
                     type:PostalAddress
                  type:Organization
                  name:University of Iceland
                  address:
                     name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Linda Magnusson
            affiliation:
                  name:University and Regional Laboratories, Skåne University Hospital, Lund University
                  address:
                     name:Department of Clinical Genetics, University and Regional Laboratories, Skåne University Hospital, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rosa B. Barkardottir
            affiliation:
                  name:Landspitali University Hospital
                  address:
                     name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
                     type:PostalAddress
                  type:Organization
                  name:University of Iceland
                  address:
                     name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cecilia Hegardt
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Markus Ringnér
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University, BMC C13
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Åke Borg
            affiliation:
                  name:Lund University
                  address:
                     name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University, BMC C13
                  address:
                     name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
                     type:PostalAddress
                  type:Organization
                  name:Lund University
                  address:
                     name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:133
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University, BMC C13
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University, BMC C13
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University, BMC C13
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University, BMC C13
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
         type:PostalAddress
      name:Landspitali University Hospital
      address:
         name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
         type:PostalAddress
      name:Landspitali University Hospital
      address:
         name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
         type:PostalAddress
      name:University of Iceland
      address:
         name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
         type:PostalAddress
      name:University and Regional Laboratories, Skåne University Hospital, Lund University
      address:
         name:Department of Clinical Genetics, University and Regional Laboratories, Skåne University Hospital, Lund University, Lund, Sweden
         type:PostalAddress
      name:Landspitali University Hospital
      address:
         name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
         type:PostalAddress
      name:University of Iceland
      address:
         name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University, BMC C13
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
         type:PostalAddress
      name:Lund University, BMC C13
      address:
         name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
         type:PostalAddress
      name:Lund University
      address:
         name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Karolina Holm
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University, BMC C13
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Johan Staaf
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University, BMC C13
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Göran Jönsson
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University, BMC C13
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Johan Vallon-Christersson
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University, BMC C13
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Haukur Gunnarsson
      affiliation:
            name:Landspitali University Hospital
            address:
               name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
               type:PostalAddress
            type:Organization
      name:Adalgeir Arason
      affiliation:
            name:Landspitali University Hospital
            address:
               name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
               type:PostalAddress
            type:Organization
            name:University of Iceland
            address:
               name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
               type:PostalAddress
            type:Organization
      name:Linda Magnusson
      affiliation:
            name:University and Regional Laboratories, Skåne University Hospital, Lund University
            address:
               name:Department of Clinical Genetics, University and Regional Laboratories, Skåne University Hospital, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Rosa B. Barkardottir
      affiliation:
            name:Landspitali University Hospital
            address:
               name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
               type:PostalAddress
            type:Organization
            name:University of Iceland
            address:
               name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
               type:PostalAddress
            type:Organization
      name:Cecilia Hegardt
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Markus Ringnér
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University, BMC C13
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
               type:PostalAddress
            type:Organization
      name:Åke Borg
      affiliation:
            name:Lund University
            address:
               name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University, BMC C13
            address:
               name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
               type:PostalAddress
            type:Organization
            name:Lund University
            address:
               name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
      name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
      name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
      name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
      name:Department of Clinical Genetics, University and Regional Laboratories, Skåne University Hospital, Lund University, Lund, Sweden
      name:Department of Pathology, Laboratory of Cell Biology, Landspitali University Hospital, Reykjavik, Iceland
      name:Faculty of Medicine, University of Iceland, Reykjavik, Iceland
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
      name:Department of Oncology, Clinical Sciences, Lund University, Lund, Sweden
      name:CREATE Health Strategic Centre for Translational Cancer Research, Lund University, BMC C13, Lund, Sweden
      name:Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(174)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Foundation
  • Prism.js

CDN Services {📦}

  • Crossref

4.81s.